NCT04450550

Electrical Vestibular Nerve Stimulation (VeNS) in the Management of Parkinson's Disease

Electrical Vestibular Neve Stimulation(VeNS) in the Management of Parkinson's Disease

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Neurovalens Ltd. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

Parkinson's disease burdens an increasing number of elderly populations in the country. Parkinson disease is a chronic, progressive neurodegenerative disorder, affects approximately 1% of the population by the age of 65 years and 4% to 5% of the population by the age of 85 years. Mild cognitive impairment in Parkinson's disease leads to Parkinson's disease dementia (PDD) for which currently there is no drug therapy. The existing treatments for PD were associated with side effects and does not offer complete cure. Hence there is a need of alternative therapy which can prevent or delay the onset of PD with less or no side effects. Vestibular stimulation is known to modulate cognitive processing, enhance learning and spatial memory. Vestibular dysfunction is present in PD patients. So long term vestibular stimulation may be effective in enhancing cognition by reducing the cognitive, neurodegenerative, neuroinflammatory changes and behavioral deficits observed as predictors of Mild Cognitive Impairment in Parkinson's disease Dementia. In this project, the plan is to administer electric vestibular nerve stimulation to PD patients which might be effective and ideal treatment with minimum or no side effects in the management of Parkinson's disease.

Conditions

• Parkinson Disease

Interventions

Type	Name	Description
DEVICE	VeNS device	VeNS treatment
DEVICE	Sham VeNS device	Sham treatment of VeNS

Timeline

• Start date: 2021-07-26
• Primary completion: 2022-11-01
• Completion: 2022-11-01
• First posted: 2020-06-29
• Last updated: 2023-04-27

Locations

1 site across 1 country: India